[HTML][HTML] Long-term microdystrophin gene therapy is effective in a canine model of Duchenne muscular dystrophy
Duchenne muscular dystrophy (DMD) is an incurable X-linked muscle-wasting disease
caused by mutations in the dystrophin gene. Gene therapy using highly functional …
caused by mutations in the dystrophin gene. Gene therapy using highly functional …
Long-term microdystrophin gene therapy is effective in a canine model of Duchenne muscular dystrophy
C Le Guiner, L Servais, M Montus, T Larcher… - Nature …, 2017 - ideas.repec.org
Duchenne muscular dystrophy (DMD) is an incurable X-linked muscle-wasting disease
caused by mutations in the dystrophin gene. Gene therapy using highly functional …
caused by mutations in the dystrophin gene. Gene therapy using highly functional …
[HTML][HTML] Long-term microdystrophin gene therapy is effective in a canine model of Duchenne muscular dystrophy
C Le Guiner, L Servais, M Montus, T Larcher… - Nature …, 2017 - ncbi.nlm.nih.gov
Duchenne muscular dystrophy (DMD) is an incurable X-linked muscle-wasting disease
caused by mutations in the dystrophin gene. Gene therapy using highly functional …
caused by mutations in the dystrophin gene. Gene therapy using highly functional …
Long-term microdystrophin gene therapy is effective in a canine model of Duchenne muscular dystrophy
C Le Guiner, L Servais, M Montus, T Larcher… - Nature …, 2017 - ora.ox.ac.uk
Duchenne muscular dystrophy (DMD) is an incurable X-linked muscle-wasting disease
caused by mutations in the dystrophin gene. Gene therapy using highly functional …
caused by mutations in the dystrophin gene. Gene therapy using highly functional …
Long-term microdystrophin gene therapy is effective in a canine model of Duchenne muscular dystrophy
CL Guiner, L Servais, M Montus… - Nature …, 2017 - econpapers.repec.org
Duchenne muscular dystrophy (DMD) is an incurable X-linked muscle-wasting disease
caused by mutations in the dystrophin gene. Gene therapy using highly functional …
caused by mutations in the dystrophin gene. Gene therapy using highly functional …
Long-term microdystrophin gene therapy is effective in a canine model of Duchenne muscular dystrophy
C Le Guiner, L Servais, M Montus… - Nature …, 2017 - ui.adsabs.harvard.edu
Duchenne muscular dystrophy (DMD) is an incurable X-linked muscle-wasting disease
caused by mutations in the dystrophin gene. Gene therapy using highly functional …
caused by mutations in the dystrophin gene. Gene therapy using highly functional …
Long-term microdystrophin gene therapy is effective in a canine model of Duchenne muscular dystrophy
C Le Guiner, L Servais, M Montus, T Thibaut, B Fraysse… - 2017 - agris.fao.org
Duchenne muscular dystrophy (DMD) is an incurable X-linked muscle-wasting disease
caused by mutations in the dystrophin gene. Gene therapy using highly functional …
caused by mutations in the dystrophin gene. Gene therapy using highly functional …
Long-term microdystrophin gene therapy is effective in a canine model of Duchenne muscular dystrophy
CC Le Guiner, L Servais, M Montus, T Thibaut… - Nature …, 2017 - hal.science
Duchenne muscular dystrophy (DMD) is an incurable X-linked muscle-wasting disease
caused by mutations in the dystrophin gene. Gene therapy using highly functional …
caused by mutations in the dystrophin gene. Gene therapy using highly functional …
Long-term microdystrophin gene therapy is effective in a canine model of Duchenne muscular dystrophy.
C Le Guiner, L Servais, M Montus, T Larcher… - Nature …, 2017 - europepmc.org
Duchenne muscular dystrophy (DMD) is an incurable X-linked muscle-wasting disease
caused by mutations in the dystrophin gene. Gene therapy using highly functional …
caused by mutations in the dystrophin gene. Gene therapy using highly functional …
Long-term microdystrophin gene therapy is effective in a canine model of Duchenne muscular dystrophy
C Le Guiner, L Servais, M Montus… - Nature …, 2017 - pubmed.ncbi.nlm.nih.gov
Duchenne muscular dystrophy (DMD) is an incurable X-linked muscle-wasting disease
caused by mutations in the dystrophin gene. Gene therapy using highly functional …
caused by mutations in the dystrophin gene. Gene therapy using highly functional …